TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00820313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00820313 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00240448 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04506333 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02708420 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04090060 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03487367 — Predictive Biomarker (PRD): ATXN1 mRNA
Genes: ATXN1; ATX1; SCA1
Study NCT03487367 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study NCT00970463 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04095962 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04095962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02734537 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02734537 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00243984 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02764749 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00975013 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02203916 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01856894 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT01832051 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03095300 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01837511 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study NCT01837511 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT01837511 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT01019798 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01019798 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01019798 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01506661 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03600649 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT03497364 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04778865 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04405492 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02920502 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01460238 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT03320330 — Predictive Biomarker (PRD): SEMA4D mRNA
Genes: SEMA4D; C9orf164; CD100; SEMAJ
Study NCT02355665 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT03501381 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01738152 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01738152 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02940262 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03548961 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00242710 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02333526 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03769311 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT01235910 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03003676 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03003676 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00759967 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05625100 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study NCT00957463 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00550784 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03243331 — Predictive Biomarker (PRD): PTK7 mRNA
Genes: PTK7; CCK4
Study NCT02370888 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04029571 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01439178 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02778529 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01143545 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02196480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01983800 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04525287 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02764762 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00982189 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01591252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01591252 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01591252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01591252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03930017 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00772174 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01217619 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01530607 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT01530607 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04055415 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03359226 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT03523052 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT03011424 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study NCT01861223 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00035906 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04683770 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04683770 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02834936 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03644524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04626271 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT02361411 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05372835 — Surrogate Endpoint (SUR): Bacterial count
Study NCT00099476 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01171300 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03246009 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT03246009 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02216578 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT02216578 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01627470 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04141241 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04266002 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04266002 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04266002 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT04266002 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT04266002 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04266002 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04266002 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT04266002 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT02792647 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01346059 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01346059 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01611935 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT04122742 — Predictive Biomarker (PRD): CREBBP mRNA
Genes: CREBBP; CBP
Study NCT04122742 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT04122742 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT04690556 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04423224 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00644878 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00644878 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00548847 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04933981 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03232034 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03232034 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01642095 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT01284712 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03559842 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02385864 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04003597 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03737461 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00805649 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02830620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02830620 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT00049881 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02569645 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT00917540 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03254849 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03254849 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02810041 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02810041 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04558476 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02690545 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01987583 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02505360 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01438892 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01093066 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02345330 — Safety Biomarker (SAF): Interleukin 12
Study NCT04635813 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01851122 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00996060 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02503514 — Predictive Biomarker (PRD): TNFSF13 mRNA
Genes: TNFSF13; APRIL; TALL2; ZTNF2; UNQ383/PRO715
Study NCT01600092 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03001895 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03511482 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02982083 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02392429 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT04429035 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT01584518 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01411150 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT03678233 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00503685 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00503685 — Predictive Biomarker (PRD): IGFBP2 mRNA
Genes: IGFBP2; BP2; IBP2
Study NCT00503685 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04250688 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06071156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01276392 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00600665 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00712803 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00159198 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00159198 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03251950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04199143 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT01722656 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01722656 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03063450 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03063450 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01608841 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01608841 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02342262 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02752048 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04982484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02019992 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT02430077 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT04481711 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05053282 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00067782 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT02014584 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05442502 — Predictive Biomarker (PRD): OGT mRNA
Genes: OGT
Study NCT00274716 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00032747 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02859896 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT01260038 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00081263 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03712488 — Predictive Biomarker (PRD): CD200 mRNA
Genes: CD200; MOX1; MOX2; My033
Study NCT03193853 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03742518 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT00967239 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00967239 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00218972 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04426136 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT00698555 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT04571697 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00244634 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01252979 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT01700010 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01700010 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03825796 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT02146027 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02685163 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04510025 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01008098 — Safety Biomarker (SAF): BDNF
Study NCT06341244 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01175655 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03455777 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT03455777 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00524615 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03261557 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study NCT03485404 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04443166 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01587235 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01587235 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT04017897 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04017897 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT05215977 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00578370 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00116116 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00116116 — Surrogate Endpoint (SUR): Undetectable plasma HIV RNA
Study NCT01771406 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01341028 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT03797391 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study NCT01748825 — Pharmacodynamic Biomarker (PDY): Cyclin-dependent kinase 1
Genes: CDK1; CDC2; CDC28A; CDKN1; P34CDC2
Study NCT01259661 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04124549 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01476839 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT05905185 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05905185 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05905185 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03951558 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03348267 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03903887 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01260610 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00796029 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00796029 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00796029 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00842023 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03882645 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01589705 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04528693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04528693 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT04528693 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02772627 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT06138704 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01031680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00172575 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00172575 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT00172575 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04134884 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04134884 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04134884 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03611803 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03617055 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00017290 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03964792 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04154280 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03441698 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03754764 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT01903616 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02893332 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00605566 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00605566 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02554773 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02554773 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT00469859 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01659099 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03577444 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03577444 — Safety Biomarker (SAF): BDNF
Study NCT04626674 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD